Speaker Profile
PMWC LUMINARY AWARD
Shaped modern single-cell genomics and AI-driven drug discovery
Ph.D., Head, Executive Vice President, Genentech Research and Early Development, Genentech
Biography
Dr Regev joined Genentech in August 2020 as Head and Executive Vice President, Genentech Research and Early Development. In this role, she is responsible for the management of all aspects of gRED’s drug discovery and drug development activities. In addition, Dr Regev is a member of the Genentech Executive Committee and Board of Directors, and a member of the expanded Corporate Executive Committee for Roche. She also run an active research lab focused on developing and applying experimental methods and computational algorithms to decipher intra- and intercellular circuits in cells in tissues.
Prior to Genentech, Dr. Regev served as Chair of the Faculty, Core Institute Member (currently on leave), Founding Director of the Klarman Cell Observatory, and member of the Executive Leadership Team of the Broad Institute of MIT and Harvard, as well as Professor of Biology at MIT (currently on leave) and Investigator at the Howard Hughes Medical Institute. She is a founding co-chair of the Human Cell Atlas.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Serge Saxonov, 10x Genomics
PMWC Award Ceremony
• Sarah Teichmann, Wellcome Sanger Institute (Luminary)
• Aviv Regev, Genentech (Pioneer)
Featured Speakers
• Sarah Teichmann, Wellcome Sanger Institute
• Aviv Regev, Genentech
• Eric Lander, Broad Institute
• Gad Getz, Broad Institute
• Emma Lundberg, Stanford
• Garry Nolan, Stanford
• Nikhil Wagle, Genentech
• Satish Viswanath, Emory
• Alex Shalek, MIT / Broad Institute
• Christina Curtis, Stanford
• Fei Chen, Broad Institute
• Andy Beck, PathAI
• Kevin Wei, Harvard
• Rebecca Critchley-Thorne, Castle Biosciences
• Dan Rozelle, Rancho BioSciences
• Maximilian Strauss, OmicVision
The Next Map of Biology
From the Human Genome to the Human Cell Atlas in the AI era.
Spatial Biology in Practice
From tissue architecture to decisions that change the answer.
Spatial Proteomics
Cell states, therapeutic targets, and what can be measured in context.
Spatial Pathology from Discovery to Clinical Biomarker
Turning a beautiful image into a validated test.
AI for Spatial Biology
Foundation models, digital pathology, and tissue-scale interpretation.
Scaling Spatial Biology to Clinical Translation
From discovery platform to reproducible clinical evidence.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
